Nasdaq podd.

How much is Insulet stock worth today? ( NASDAQ: PODD) Insulet currently has 69,821,118 outstanding shares. With Insulet stock trading at $162.58 per share, the total value of Insulet stock (market capitalization) is $11.35B. Insulet stock was originally listed at a price of $15.96 in May 15, 2007.

Nasdaq podd. Things To Know About Nasdaq podd.

Jan 12, 2023 · Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. Nov 29, 2023 · The latest price target for . Insulet (NASDAQ: PODD) was reported by Piper Sandler on Friday, November 3, 2023.The analyst firm set a price target for 250.00 expecting PODD to rise to within 12 ... The latest price target for . Insulet (NASDAQ: PODD) was reported by Piper Sandler on Friday, November 3, 2023.The analyst firm set a price target for 250.00 expecting PODD to rise to within 12 ...Oct 17, 2023 · Fintel. Fintel reports that on October 17, 2023, JP Morgan maintained coverage of Insulet (NASDAQ:PODD) with a Overweight recommendation. Analyst Price Forecast Suggests 109.29% Upside As of ...

Insulet (PODD) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.42 per share a year ago. These figures ...

As of August 2, 2023, the average one-year price target for Insulet is 360.72. The forecasts range from a low of 322.19 to a high of $414.75. The average price target represents an increase of 83. ...

Written by Zacks Equity Research for Zacks ->. Insulet PODD is scheduled to report third-quarter 2023 results on Nov 1, after market close. In the last reported quarter, the company’s adjusted ...Sep 28, 2023 · Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its ... PODD Latest Pre Market Trades. Select time range to see more trades: Last 100 Trades. Pre-Market Time (ET) Pre-Market Price. Pre-Market Share Volume. 09:29:46. $231.39.The price-to-earnings ratio for Insulet Corporation (NASDAQ: PODD) is above average at 92.44x. The 36-month beta value for PODD is also noteworthy at 0.87. There are mixed opinions on the stock, with 15 analysts rating it as a “buy,” 3 rating it as “overweight,” 6 rating it as “hold,” and 0 rating it as “sell.”.

Insulet Corporation (NASDAQ:PODD) is a prime example of this. The company makes a tubeless pump, called an Omnipod, for people with diabetes. The company makes a tubeless pump, called an Omnipod ...

Find the latest analyst research for Insulet Corporation Common Stock (PODD) at Nasdaq.com.

Fintel. Fintel reports that on October 17, 2023, JP Morgan maintained coverage of Insulet (NASDAQ:PODD) with a Overweight recommendation. Analyst Price Forecast Suggests 109.29% Upside As of ...PODD Latest Real Time Trades. Select time range to see more trades: Last 100 Trades. ... PODD Latest Pre Market Trades. Select time range to see more trades: Last 100 Trades. Pre-Market Time (ET) Pre-Market Price. Pre-Market Share Volume. 09:29:46. $231.39. Earnings for Insulet are expected to grow by 29.84% in the coming year, from $1.91 to $2.48 per share. Insulet has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 22nd, 2024 based off prior year's report dates. Read More.On March 10, 2023, Insulet Corporation (NASDAQ:PODD) stock closed at $280.36 per share. One-month return of Insulet Corporation (NASDAQ:PODD) was -6.11%, and its shares gained 32.27% of their ...The image below, which you can click on for greater detail, shows that at June 2022 Insulet had debt of US$1.41b, up from US$1.26b in one year. However, it does have US$708.6m in cash offsetting ...

Insulet Corporation (NASDAQ: PODD)’s stock price has gone rise by 5.55 in comparison to its previous close of 155.10, however, the company has experienced a 3.01% increase in its stock price over the last five trading days. Zacks Investment Research reported 2023-11-10 that Insulet (PODD) could produce exceptional returns because of its solid growth attributes. […]While the historical EPS growth rate for Insulet is 52.2%, investors should actually focus on the projected growth. The company's EPS is expected to grow 1741.4% this year, crushing the industry ...Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.'Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods.Insulet Corporation (NASDAQ: PODD)’s stock price has gone rise by 0.09 in comparison to its previous close of 188.92, however, the company has experienced a 1.49% increase in its stock price over the last five trading days. Business Wire reported 2023-11-28 that ACTON, Mass.–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin […]

Jul 24, 2023 · One-month return of Insulet Corporation (NASDAQ:PODD) was -4.20%, and its shares gained 18.16% of their value over the last 52 weeks. Insulet Corporation (NASDAQ:PODD) has a market capitalization ... A high-level overview of Insulet Corporation (PODD) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Insulet Corporation PODD reported adjusted earnings per share (EPS) of 71 cents for third-quarter 2023, improving from the year-ago period’s adjusted EPS of 45 cents per share.PODD Insulet Corp NASDAQ 188.51 -0.41 -0.22% Opening 13:12 11/30 EST OPEN 188.80 PREV CLOSE 188.92 HIGH 190.29 LOW 185.73 VOLUME 276.05K TURNOVER 0 52 …Insulet Corporation PODD reported adjusted earnings per share (EPS) of 71 cents for third-quarter 2023, improving from the year-ago period’s adjusted EPS of 45 cents per share.Insulet (PODD) closed the most recent trading day at $298.61, moving +1.28% from the previous trading session. The stock outpaced the S&P 500's daily gain of 1.15%. At the same time, the Dow added ...Dec 4, 2023 · In the last 3 months, 8 analysts have offered 12-month price targets for Insulet. The company has an average price target of $212.25 with a high of $250.00 and a low of $162.00. Below is a summary ... Fintel reports that on August 21, 2023, Citigroup upgraded their outlook for Insulet (NASDAQ:PODD) from Neutral to Buy.. Analyst Price Forecast Suggests 83.58% Upside. As of August 2, 2023, the ..."Insulet Corporation (NASDAQ:PODD) is a medical device company focused on the design, development and commercialization of insulin pump systems for people with type 1 diabetes. Diabetes is a ...Insulet (NASDAQ:PODD - Get Free Report) was upgraded by stock analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating in a research …Turning to the calls side of the option chain, the call contract at the $320.00 strike price has a current bid of $61.00. If an investor was to purchase shares of PODD stock at the current price ...Dec 1, 2023 · Insulet (NASDAQ:PODD) and Teleflex are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, media sentiment, community ranking, dividends and earnings.

03-Nov-2023 ... On the stock market today, Insulet stock surged 15.8% to close at 162.58. That put PODD stock among the top three best-performing stocks in the ...

Insulet Corporation (NASDAQ: PODD)’s stock price has plunge by 4.14relation to previous closing price of 174.06. Nevertheless, the company has seen a 10.72% surge in its stock price over the last five trading sessions. Zacks Investment Research reported 2023-11-10 that Insulet (PODD) could produce exceptional returns …

Insulet (NASDAQ: PODD) is an innovative medical device company improving the lives of people with diabetes and other conditions through its Omnipod delivery system. Simplifying lives for people with diabetes is our passion and our purpose .Mar 20, 2023 · Insulet Corporation (NASDAQ:PODD) is a prime example of this. The company makes a tubeless pump, called an Omnipod, for people with diabetes. The company makes a tubeless pump, called an Omnipod ... PODD Latest Pre Market Trades. Select time range to see more trades: Last 100 Trades. Pre-Market Time (ET) Pre-Market Price. Pre-Market Share Volume. 09:29:46. $231.39. Insulet Corporation (NASDAQ: PODD)’s stock price has gone rise by 5.55 in comparison to its previous close of 155.10, however, the company has experienced a 3.01% increase in its stock price over the last five trading days. Zacks Investment Research reported 2023-11-10 that Insulet (PODD) could produce exceptional returns because of …Insulet Corporation (NASDAQ:PODD) Q3 2023 Earnings Call Transcript (Insider Monkey) 08:07AM Q3 2023 Insulet Corp Earnings Call (Thomson Reuters StreetEvents) Nov-02-23 07:01PM Insulet Corp (PODD) Reports 27% Revenue Increase in Q3 2023 (GuruFocus.com) 05:30PM Insulet (PODD) Q3 Earnings: Taking a Look at Key Metrics …Based on this analysis, Insulet (NASDAQ:PODD) appears to be significantly undervalued, with a market cap of $11.70 billion. Given its significant undervaluation, the long-term return of Insulet's ...241% 112% Who Is the Motley Fool? Other Services Insulet (NASDAQ: PODD) $187.95 (0.9%) $1.64 Price as of November 24, 2023, 1:00 p.m. ET Financial Health Earnings Transcripts Key Data Points...Insulet stock (NASDAQ NDAQ: PODD) currently trades at $156 per share, about 29% lower than the level seen in early June 2022, just before the Fed started increasing rates, compared to 14% gains ...PODD Latest Pre Market Trades. Select time range to see more trades: Last 100 Trades. Pre-Market Time (ET) Pre-Market Price. Pre-Market Share Volume. 09:29:46. $231.39. (PODD) Latest Real Time Trades | Nasdaq Real-Time: PODD Edit my quotes Insulet Corporation Common Stock (PODD) 0 Add to Watchlist Add to Portfolio PODD PODD …

On the daily chart, the RSI 20 is at the most oversold level the stock has ever been. The last tDespite posting decent earnings, NASDAQ:PODD has been weathering a massive selloff and is now in its historically strong …Dec 4, 2023 · In the last 3 months, 8 analysts have offered 12-month price targets for Insulet. The company has an average price target of $212.25 with a high of $250.00 and a low of $162.00. Below is a summary ... There are 1359 funds or institutions reporting positions in Insulet. This is an increase of 215 owner (s) or 18.79% in the last quarter. Average portfolio weight of all funds dedicated to PODD is ...Instagram:https://instagram. should i buy tesla1979 dollar coin fgbest rental property lendersbest medical insurance in minnesota 01-Nov-2023 ... Insulet (Nasdaq:PODD) today announced a series of initiatives to recognize National Diabetes Awareness Month and World Diabetes Day.Insulet Corporation PODD reported adjusted earnings per share (EPS) of 71 cents for third-quarter 2023, improving from the year-ago period’s adjusted EPS of 45 cents per share. argljb hunt trucking Investors should also consider Insulet (NASDAQ: PODD), a medical device company that specializes in insulin pump systems for people with diabetes.The company is well known for its ‘Omnipod ... stocks with most buy ratings Shares of Insulet ( PODD 0.88%) were down 12.2% for the week as of Thursday's close, according to data provided by S&P Global Market Intelligence. The healthcare stock closed last week at $145.51 ...Read Our Latest Report on PODD. Insulet Stock Up 1.6 %. Shares of NASDAQ:PODD opened at $192.19 on Friday. The stock has a market capitalization of …Insulet (PODD) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.42 per share a year ago. These figures ...